Palmoplantar Pustulosis (PPP) Case Study

Click here for a PDF version of this case study

Innovation in dermatology research icon


Innovaderm successfully managed this PPP study
and this resulted in:

Enrollment completed 3 weeks ahead of schedule;
Successful study and satisfied sponsor


Study Characteristics

    • Study Phase: II
    • Patient Population: Palmoplantar pustulosis
    • IP Route of Administration: Systemic
    • Sites Distribution: 17 sites in 2 countries (Canada, Germany)
    • Study Complexities: Presence of active lesions required, high PPPASI and PPPGA



    Study Challenges and Solutions




    Dermatology service icon


    Site Selection

    • Identification of sites due to limited pool of patients with rare diseases
      • Early activation of sites in Germany
      • Timely assessment of potential challenges with site selection
      • Implementation of in-house central campaign

    Outcome: Enrollment completed 3 weeks ahead of schedule

    Phone job interview



    • Participant apprehension regarding biopsy consent
    • Hassle of transporting IP between site and patient's home
    • Short treatment period deterred interest in participation
      • Strong presence of on-site staff to address questions or concerns related to participation 

    Outcome: Successful study and satisfied sponsor (+40%)



Key Success Factors & Strategies

During the clinical study icon Activation of sites in Germany to bolster recruitment

During the clinical study icon Effective in-house central campaigns

During the clinical study icon Project team’s tremendous engagement with sites to drive recruitment



Recruitment Curve and Site Activation


Enrollment was completed 3 weeks earlier than planned




Contact us

Get notified to have the latest trends and be at the forefront of dermatology clinical research and innovation.

Subscribe to our newsletter

Innovaderm Research Wave